Bausch Health Companies BHC
NYSE BHC
$6.16 -0.26 (-4.12%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Other Operating Expenses (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Other Operating Expenses came in at -$26.0 million in Q2 2026, down 244.44% year-over-year from $18.0 million in Q2 2025, and up 18.75% quarter-over-quarter from -$32.0 million in Q1 2026.

Analysis

Bausch Health Companies (BHC) Other Operating Expenses (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Other Operating Expenses across 18 years of filings, most recently posting -$26.0 million for Q2 2026.

  • In Q2 2026, Other Operating Expenses fell 244.44% year-over-year to -$26.0 million; the TTM figure through Jun 2026 stood at -$203.0 million (up 9.38% YoY), while the FY2025 annual figure was -$142.0 million, up 42.51% from the prior year.
  • Other Operating Expenses came in at -$26.0 million for Q2 2026 at Bausch Health Companies, up from -$32.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $83.0 million in Q2 2023 to a low of -$225.0 million in Q3 2024.
  • Average Other Operating Expenses over 5 years is -$31.9 million, with a median of -$24.5 million recorded in 2023.
  • The largest YoY upside for Other Operating Expenses was 190.0% in 2025 against a maximum downside of 3150.0% in 2025.
  • Over 5 years, Other Operating Expenses stood at -$29.0 million in 2022, then advanced by 3.45% to -$28.0 million in 2023, then soared by 92.86% to -$2.0 million in 2024, then slumped by 3150.0% to -$65.0 million in 2025, then jumped by 60.0% to -$26.0 million in 2026.
  • Per Business Quant data, the three most recent Other Operating Expenses figures were -$26.0 million in Q2 2026, -$32.0 million in Q1 2026, and -$65.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -26.00 Mn
Mar 31, 2026 -32.00 Mn
Dec 31, 2025 -65.00 Mn
Sep 30, 2025 -80.00 Mn
Jun 30, 2025 18.00 Mn
Mar 31, 2025 -15.00 Mn
Dec 31, 2024 -2.00 Mn
Sep 30, 2024 -225.00 Mn
Jun 30, 2024 -20.00 Mn
Dec 31, 2023 -28.00 Mn
Sep 30, 2023 -60.00 Mn
Jun 30, 2023 83.00 Mn
Mar 31, 2023 -23.00 Mn
Dec 31, 2022 -29.00 Mn
Sep 30, 2022 -4.00 Mn
Mar 31, 2022 -2.00 Mn
Dec 31, 2021 -44.00 Mn
Sep 30, 2021 183.00 Mn
Jun 30, 2021 -542.00 Mn
Mar 31, 2021 30.00 Mn